spacer
home > ebr > > pharma research meets synthetic biology
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

Industry Events

Outsourcing in Clinical Trials Medical Devices 2016

12-13 July 2016, Irvine, California, USA

Arena International is thrilled to announce that after another successful event in Minneapolis in 2015 we are moving to Irvine, California for 2016!
More info >>

 
News and Press Releases

AMRI to Acquire Euticals in a Strategic Transaction That Expands its API Development and Manufacturing Business

AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all outstanding shares of Prime European Therapeuticals S.p.A., also known as "Euticals", in a transaction valued at approximately $358 million (EUR 315 million), consisting of shares of AMRI common stock, cash, and a seller note.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement